Development Level

Tbio 60 | 11,651
Tdark 6 | 6,593
Tchem 1 | 1,388

IMPC Phenotype

preweaning lethality, complete... 10 | 979
embryonic lethality prior to o... 4 | 239
decreased vertical activity 3 | 208
embryonic lethality prior to t... 3 | 278
abnormal behavior 2 | 298
abnormal embryo size 2 | 220
decreased lymphocyte cell numb... 2 | 83
decreased mean corpuscular hem... 2 | 31
decreased neutrophil cell numb... 2 | 42
enlarged heart 2 | 210
male infertility 2 | 123
abnormal behavioral response t... 1 | 66
abnormal bone structure 1 | 187
abnormal coat- hair morphology 1 | 19
abnormal embryo turning 1 | 31
abnormal locomotor behavior 1 | 24
abnormal neural tube closure 1 | 46
abnormal spine curvature 1 | 9
decreased IgE level 1 | 6
decreased bone mineral content 1 | 151
decreased circulating HDL chol... 1 | 68
decreased circulating alanine ... 1 | 47
decreased circulating chloride... 1 | 30
decreased circulating choleste... 1 | 93
decreased circulating free fat... 1 | 31
decreased circulating glucose ... 1 | 126
decreased circulating potassiu... 1 | 20
decreased circulating thyroxin... 1 | 2
decreased cornea thickness 1 | 2
decreased eosinophil cell numb... 1 | 24
decreased food intake 1 | 13
decreased grip strength 1 | 116
decreased lean body mass 1 | 135
decreased leukocyte cell numbe... 1 | 73
decreased startle reflex 1 | 75
decreased total retina thickne... 1 | 17
embryonic growth retardation 1 | 106
female infertility 1 | 60
hyperactivity 1 | 148
hypoactivity 1 | 132
increased bone mineral content 1 | 108
increased fasted circulating g... 1 | 76
increased heart weight 1 | 62
increased hematocrit 1 | 46
increased lymphocyte cell numb... 1 | 32
increased mean corpuscular vol... 1 | 92
increased mean platelet volume 1 | 45
increased neutrophil cell numb... 1 | 46
increased total body fat amoun... 1 | 134
increased urine magnesium leve... 1 | 2
prenatal lethality prior to he... 1 | 87
preweaning lethality, incomple... 1 | 499
small testis 1 | 58

Disease

Carcinoma 54 | 11,493
ovarian cancer 39 | 8,519
osteosarcoma 37 | 7,950
group 3 medulloblastoma 29 | 4,104
medulloblastoma, large-cell 29 | 6,241
glioblastoma 27 | 5,792
ependymoma 25 | 4,679
psoriasis 25 | 6,694
astrocytic glioma 24 | 2,597
oligodendroglioma 22 | 2,850
lung cancer 21 | 4,740
atypical teratoid / rhabdoid tumor 20 | 5,112
primitive neuroectodermal tumor 20 | 3,035
Kidney cancer 18 | 2,613
intraductal papillary-mucinous carcinoma (IPMC) 17 | 2,988
malignant mesothelioma 17 | 3,232
Breast cancer 16 | 3,577
Pick disease 16 | 1,894
acute quadriplegic myopathy 15 | 1,158
intraductal papillary-mucinous adenoma (IPMA) 14 | 2,954
adult high grade glioma 13 | 3,801
Multiple myeloma 12 | 1,332
dermatomyositis 12 | 966
Waldenstrons macroglobulinemia 11 | 765
invasive ductal carcinoma 11 | 2,950
Astrocytoma, Pilocytic 10 | 3,081
juvenile dermatomyositis 10 | 1,187
lung adenocarcinoma 10 | 2,716
non-small cell lung cancer 10 | 2,890
Rheumatoid arthritis 9 | 1,191
lung carcinoma 9 | 2,843
pediatric high grade glioma 9 | 1,064
progressive supranuclear palsy 9 | 676
subependymal giant cell astrocytoma 9 | 2,287
Amyotrophic lateral sclerosis 8 | 451
cystic fibrosis 8 | 1,695
diabetes mellitus 8 | 1,728
group 4 medulloblastoma 8 | 1,855
intraductal papillary-mucinous neoplasm (IPMN) 8 | 3,290
pancreatic ductal adenocarcinoma liver metastasis 8 | 1,962
non primary Sjogren syndrome sicca 7 | 891
ductal carcinoma in situ 6 | 1,744
pituitary cancer 6 | 1,972
tuberculosis and treatment for 6 months 6 | 409
Cancer 5 | 2,499
Intellectual disability 5 | 1,016
Schizophrenia 5 | 1,160
astrocytoma 5 | 1,146
autosomal dominant Emery-Dreifuss muscular dystrophy 5 | 510
breast carcinoma 5 | 1,637
colon cancer 5 | 1,478
pancreatic cancer 5 | 2,398
ulcerative colitis 5 | 1,819
Alzheimer's disease 4 | 658
active Crohn's disease 4 | 922
atypical teratoid/rhabdoid tumor 4 | 357
hepatocellular carcinoma 4 | 547
interstitial lung disease 4 | 298
spina bifida 4 | 1,074
tuberculosis 4 | 2,010
Adult onset 3 | 82
Bipolar Disorder 3 | 666
Breast Neoplasms 3 | 445
Cataract 3 | 297
Creatine phosphokinase serum increased 3 | 110
Dull intelligence 3 | 645
Elevated creatine kinase 3 | 110
Glaucoma 3 | 239
Lens Opacities 3 | 231
Liver Cirrhosis, Experimental 3 | 769
Liver cancer 3 | 604
Low intelligence 3 | 645
Mammary Neoplasms 3 | 425
Mental Retardation 3 | 645
Mental deficiency 3 | 645
Ophthalmoplegia 3 | 106
Optic Atrophy 3 | 242
Poor school performance 3 | 645
Type 2 diabetes mellitus 3 | 272
active ulcerative colitis 3 | 764
acute myeloid leukemia 3 | 783
adrenocortical carcinoma 3 | 1,428
gastric cancer 3 | 459
primary Sjogren syndrome 3 | 735
relapsing-remitting multiple sclerosis 3 | 18
Acquired scoliosis 2 | 281
Atopic dermatitis 2 | 952
Choreatic disease 2 | 52
Curvature of spine 2 | 282
Distal muscle weakness 2 | 62
Duchenne muscular dystrophy 2 | 601
Hyperreflexia 2 | 209
Myopathy 2 | 185
Neurodegenerative disease 2 | 414
Neuropathy 2 | 261
Polycystic ovary syndrome 2 | 360
Prostatic Neoplasms 2 | 495
chronic lymphosyte leukemia 2 | 204
fibroadenoma 2 | 559
pancreatic carcinoma 2 | 562

Tissue

Digestive Tract 66 | 17,369
Endocrine System 66 | 18,159
Blood and immune system 65 | 16,909
Liver and Pancreas 65 | 16,750
Male tissues 65 | 17,142
Nervous System 65 | 16,725
Skin and soft tissues 65 | 17,230
Female tissues 64 | 17,400
Respiratory system 64 | 16,393
Cardiovascular System 63 | 15,192
Urinary Tract 63 | 16,678

Target Family

Non-IDG 42 | 12,091
Enzyme 24 | 4,145
Epigenetic 1 | 242

GO Process

RNA processing 67 | 67
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
DNA-binding death effector domain-containing protein 2 DEDD2 Tbio Non-IDG -0.55115 3.37 164
RNA-binding protein 39 RBM39 Tbio Non-IDG -0.95639 9.80 199
Heterogeneous nuclear ribonucleoprotein H HNRNPH1 Tbio Non-IDG -1.71562 50.9 205
RNA-binding protein 4 RBM4 Tbio Non-IDG -1.71130 51.9 162
RNA-binding protein with multiple splicing RBPMS Tbio Non-IDG -2.12771 131.9 266
Putative ATP-dependent RNA helicase DHX57 DHX57 Tdark Enzyme 0.23 0.58 43
Heterogeneous nuclear ribonucleoprotein F HNRNPF Tbio Non-IDG -1.61647 39.6 212
RNA-binding protein 5 RBM5 Tbio Non-IDG -1.63140 51.6 193
Adenosine deaminase domain-containing protein 2 ADAD2 Tdark Enzyme 0.23 0.43 53
U6 snRNA-associated Sm-like protein LSm7 LSM7 Tbio Non-IDG -0.95219 6.58 100